𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer

✍ Scribed by Frank Riedel; Karl Götte; Wolfgang Bergler; Walter Rojas; Karl Hörmann

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
449 KB
Volume
22
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Background. Angiogenesis is crucial for tumor growth and metastasis. In several tumors, microvascular density has been shown to correlate with metastasis and aggressiveness. Basic fibroblast growth factor (bFGF) has potent angiogenic activity and has been identified in a wide variety of malignancies including head and neck squamous cell carcinomas (HNSCC).

Material and Methods. Frozen sections of 50 HNSCC were immunostained for von Willebrand factor and bFGF. Microvessels were counted by light microscopy; bFGF expression was studied at the light and electron microscopic level. Laryngeal cancer cell line HlaC79 was incubated with interferon (IFN) ␣ and ␤. bFGF quantification was performed by ELISA, and antiproliferative effects were determined by BrdU assay.

Results. The mean number of blood vessels (77.5 ± 23.7) is significantly increased in HNSCC compared with controls (17.1 ± 5.9). bFGF protein expression was detected in all HNSCC but not in control tissue. An correlation between bFGF expression and mean number of microvessels was found (p < .001). However, no correlation between bFGF expression and the main clinicopathologic features was shown. The long-term exposure (144 hr) of HNSCC cells to noncytostatic concentrations of IFN ␣ and ␤ (>10 U/mL) down-regulated the protein production of bFGF.

Conclusion. bFGF expression and angiogenesis are enhanced in HNSCC. The higher microvessel density in HNSCC with strong bFGF expression supports the importance of bFGF for tumor angiogenesis. IFN ␣ and ␤ treatment leads to a downregulation of bFGF expression independent of their antiproliferative effects, suggesting that IFN treatment might result in a reduction of angiogenesis in HNSCC.

📜 SIMILAR VOLUMES

Differential expression of epidermal gro
Differential expression of epidermal growth factor receptor in human head and neck cancers
✍ Li Dao Ke; Karen Adler-Storthz; Gary L. Clayman; Alfred W. K. Yung; Zhuo Chen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Background: Over-expression of human epidermal growth factor receptor (egfr) is associated with a variety of human malignancies, including head and neck cancer. it has also been studied for its effect on cancer cell responses to chemotherapy. to accurately measure changes in egfr expression that

Expression of bone morphogenetic protein
Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor
✍ Joachim H. Clement; Jörg Sänger; Klaus Höffken 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 219 KB 👁 2 views

Bone morphogenetic proteins (BMPs) are multifunctional regulators of proliferation, differentiation and apoptosis. BMP-6 is involved in numerous developmental processes. We have demonstrated expression of BMP-6 in breast cancer cell lines by RT-PCR and immuno-histochemistry. The level of BMP-6 mRNA

Cytoskeleton regulates expression of gen
Cytoskeleton regulates expression of genes for transforming growth factor-β1 and extracellular matrix proteins in dermal fibroblasts
✍ M. Varedi; A. Ghahary; P. G. Scott; E. E. Tredget 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Cytoskeleton not only controls cell morphology but also regulates cell growth, migration, differentiation, and gene expression, events which are fundamental to embryogenesis, carcinogenesis, and wound healing. We have recently reported that reorganization of cytoskeleton induces expression of mRNA f

Down-regulation of protein and mRNA expr
Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer
✍ Yanping Guo; Stephen C. Jacobs; Natasha Kyprianou 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 298 KB 👁 1 views

Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi